-
Healthy volunteers for Neuroinflammatory research study
We are conducting research studies on how immune system cells contribute to inflammatory conditions of the nervous system, such as ...Amit Bar-Or
-
NEUROIMMUNOLOGY PATIENT RESPONSE TO COVID-19 OUTBREAK
The purpose of this research study is to understand how our patients with Multiple Sclerosis (MS) and other neuroimmune disorders ...
-
Multicenter randomized double-blind parallel-group add-on superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with ...
This is a study to find out whether patients with active forms of Relapsing Multiple Sclerosis (RMS) who are treated ...
Eric Williamson
-
A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis ...
The purpose of this study is to compare efficacy and safety of Autologous Hematopoietic Stem Cell Transplant (AHSCT) to best ...
-
CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System BiomarKers in Multiple Sclerosis
The purpose of this study is to better understand the mechanism of action of cladribine tablets. The study will generate ...
-
Observational study of COVID-19 vaccine responses in patients with autoimmune diseases
Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo ...
-
CENTRAL VEIN SIGN: A DIAGNOSTIC BIOMARKER IN MULTIPLE SCLEROSIS
The study is a cross-sectional, multi-center study among subjects with a clinical/radiological suspicion of multiple sclerosis (MS). The study ...
Russell Shinohara
-
A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB105 Administered Intrathecally to Adults With Amyotrophic ...
This is a first in human, phase 1 trial of BIIB105, which is a novel ASO, in patients with Amyotrophic ...
Lauren Elman
-
Randomized Blinded Discontinuation Trial of Ocrelizumab in Early Relapsing Multiple Sclerosis
The primary study objective is to evaluate the rate of durable remission of relapsing disease activity, assessed serially both clinically ...
-
Advanced Neuroimaging in Multiple Sclerosis
MS is a life-long disease that can clinically manifest at a wide range of ages. Lesions in the white matter ...
Showing - of trials